Carefully targeted reimbursement strategies are the key to successfully launching new medical products in today’s cost-conscious health care environment. Our keen understanding regarding the often conflicting objectives and motivations of health care system stakeholders allows us to create actionable reimbursement strategies that support the range of reimbursement activity — from planning through implementation and ongoing support.
Boston Healthcare has a strong understanding of the reimbursement processes for pharmaceutical products, diagnostics, and medical devices, as well as the changing trends in the delivery of health care throughout the US, European, and global markets.
To aid in our US research, we have developed a payer panel of key decision makers (pharmacy and medical) in payer segments including private managed care organizations (MCOs), preferred provider organizations (PPOs) and indemnity insurers, Pharmacy Benefit Management organizations (PBMs), and technology assessment firms. We also have key contacts within Medicare and Medicaid to assess and drive positive coverage.